1. Home
  2. BELFB vs VIR Comparison

BELFB vs VIR Comparison

Compare BELFB & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bel Fuse Inc. Class B

BELFB

Bel Fuse Inc. Class B

N/A

Current Price

$166.83

Market Cap

2.2B

Sector

N/A

ML Signal

N/A

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

N/A

Current Price

$6.10

Market Cap

773.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BELFB
VIR
Founded
1949
2016
Country
United States
United States
Employees
5370
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
773.5M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
BELFB
VIR
Price
$166.83
$6.10
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
11
Target Price
$153.75
$25.73
AVG Volume (30 Days)
154.5K
1.8M
Earning Date
10-29-2025
11-05-2025
Dividend Yield
0.16%
N/A
EPS Growth
19.52
N/A
EPS
5.17
N/A
Revenue
$649,376,000.00
$16,860,000.00
Revenue This Year
$28.52
N/A
Revenue Next Year
$6.49
$48.05
P/E Ratio
$33.23
N/A
Revenue Growth
23.70
N/A
52 Week Low
$58.00
$4.16
52 Week High
$178.67
$14.45

Technical Indicators

Market Signals
Indicator
BELFB
VIR
Relative Strength Index (RSI) 56.19 48.14
Support Level $168.49 $6.49
Resistance Level $178.67 $6.97
Average True Range (ATR) 7.58 0.47
MACD 0.74 -0.02
Stochastic Oscillator 58.13 41.30

Price Performance

Historical Comparison
BELFB
VIR

About BELFB Bel Fuse Inc. Class B

Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: